Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HB Technologies is a Germany-based life science and medical technology software company that develops digital solutions for biotechnology, bioinformatics, laboratory automation, in-vitro diagnostics, and health software. Rather than operating as a therapeutic drug developer, the company provides technical software, data analytics, AI-enabled solutions, instrument integration, and process optimization services for research and industrial laboratory environments. Its offerings also include IEC 62304-compliant software development for medical devices and IVD applications, custom biomolecule production support, and distribution of laboratory instruments through its HB Instruments division. The company appears to operate commercially with long-standing experience in the sector and serves biopharma, biotech, and medtech customers from its base in Tübingen, Germany.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HB Technologies.